InMode to Present In-Person at the Barclays Global Health Conference

InMode Ltd. (NASDAQ: INMD), a global leader in innovative medical technologies, announced that its CFO Yair Malca and CMO Spero Theodorou will present at the Barclays Global Health Conference in Miami on March 15, 2023.

Rhea-AI Summary

InMode Ltd. (NASDAQ: INMD), a global leader in innovative medical technologies, announced that its CFO Yair Malca and CMO Spero Theodorou will present at the Barclays Global Health Conference in Miami on March 15, 2023. The presentation is set for 9:30 am ET and will be moderated by equity research analyst Matt Miksic. Interested parties can access the webcast via InMode's Investor Relations website. InMode will also hold one-on-one investor meetings that day. For further details, visit the investor relations site.

Argus Session date unavailable

+0.41% session move Open Argus

Details

News Market Reaction – INMD

The recorded move for INMD in the trading session of this news was +0.41%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

YOKNEAM, Israel, March 2, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present in-person at the Barclays Global Health Conference in Miami on March 15, 2023.

The fireside chat, moderated by Matt Miksic, equity research analyst, is scheduled for 9:30 am Eastern Time on Wednesday, March 15 and will be webcast from InMode's Investor Relations website at https://inmodemd.com/investors/. InMode will also hold one-on-one investor meetings in person that same day. To schedule a meeting, please contact your Barclays representative.

For more information about the event, visit InMode's investor relations site here.

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 
917-607-8654 

View original content:https://www.prnewswire.com/news-releases/inmode-to-present-in-person-at-the-barclays-global-health-conference-301758856.html

SOURCE InMode LTD

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date of InMode's presentation at the Barclays Global Health Conference?

InMode's presentation is scheduled for March 15, 2023.

Who will represent InMode at the Barclays Global Health Conference?

InMode will be represented by CFO Yair Malca and CMO Spero Theodorou.

What time is InMode's presentation at the Barclays Global Health Conference?

InMode's presentation is set for 9:30 am Eastern Time.

Where can I watch InMode's presentation at the conference?

The presentation can be accessed via InMode's Investor Relations website.

Will InMode hold one-on-one meetings at the Barclays Global Health Conference?

Yes, InMode will hold one-on-one investor meetings on the same day.